Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urinary Concentration After Salmeterol in Well-trained Men and Females
NCT06657547Phase 1Recruiting
- Sponsor
- University of Copenhagen
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of salmeterol in asthma (3 arms), sponsored by University of Copenhagen. Primary endpoint: Urine concentration of salmeterol at 1 week. Started Oct 2024; status: recruiting.
02
Drugs
salmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06657547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06657547.